Both in Pharmaceuticals
GRI Bio vs Onconetix
Over the past year GRI returned −97.6% and ONCO returned −99.7%; their daily moves had a correlation of 0.03.
GRI −97.6% ONCO −99.7%Growth of $1, one year, split-adjusted
| Metric | GRI | ONCO |
|---|---|---|
| Price | $1.38 | $0.4788 |
| Market cap | $3.0M | $2.5M |
| Today | −1.43% | −12.63% |
| 1 month | −25.0% | −27.8% |
| 6 months | −45.9% | −93.5% |
| Year to date | −80.0% | −99.4% |
| 1 year | −97.5% | −99.7% |
| Revenue growth (YoY) | — | −83.9% |
| Gross margin | — | 25.1% |
| Net margin | — | −16748.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.9× |
| Net cash | $10.9M | $5.8M |
| Dividend yield | — | — |
| Volatility (60d) | 135.7% | 150.4% |
| Short % of float | 3.2% | 14.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).